196 related articles for article (PubMed ID: 19491845)
1. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.
Talley NJ
Am J Gastroenterol; 2009 Jun; 104(6):1339-41. PubMed ID: 19491845
[No Abstract] [Full Text] [Related]
2. The FDA and IBS drug development.
Mangel AW
Am J Gastroenterol; 2009 Dec; 104(12):3106; author reply 3106. PubMed ID: 19956135
[No Abstract] [Full Text] [Related]
3. FDA approves one drug for irritable bowel syndrome but suspends another.
Harv Womens Health Watch; 2008 Aug; 15(12):7. PubMed ID: 19115501
[No Abstract] [Full Text] [Related]
4. End points in irritable bowel syndrome.
Mangel AW; Fehnel SE
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):293-5. PubMed ID: 21651345
[No Abstract] [Full Text] [Related]
5. The Food and Drug Administration approves lubiprostone for irritable bowel syndrome with constipation.
Lang L
Gastroenterology; 2008 Jul; 135(1):7. PubMed ID: 18541153
[No Abstract] [Full Text] [Related]
6. Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.
Med Lett Drugs Ther; 2008 Jul; 50(1290):53-4. PubMed ID: 18617872
[No Abstract] [Full Text] [Related]
7. Lubiprostone for constipation and irritable bowel syndrome with constipation.
Tuteja AK; Rao SS
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):727-33. PubMed ID: 19090733
[TBL] [Abstract][Full Text] [Related]
8. Eluxadoline (Viberzi) for irritable bowel syndrome with diarrhea.
Med Lett Drugs Ther; 2016 Jan; 58(1485):4-5. PubMed ID: 26714241
[No Abstract] [Full Text] [Related]
9. Peripherally acting therapies for the treatment of irritable bowel syndrome.
Saad RJ
Gastroenterol Clin North Am; 2011 Mar; 40(1):163-82. PubMed ID: 21333906
[TBL] [Abstract][Full Text] [Related]
10. The power of placebo in pediatric functional gastrointestinal disease.
Benninga MA; Mayer EA
Gastroenterology; 2009 Oct; 137(4):1207-10. PubMed ID: 19717127
[No Abstract] [Full Text] [Related]
11. FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome?
Corsetti M; Tack J
Neurogastroenterol Motil; 2013 Jun; 25(6):453-7. PubMed ID: 23672677
[TBL] [Abstract][Full Text] [Related]
12. Eluxadoline approved for irritable bowel syndrome with diarrhea.
Traynor K
Am J Health Syst Pharm; 2015 Jul; 72(13):1078. PubMed ID: 26092951
[No Abstract] [Full Text] [Related]
13. Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.
Schiller LR; Johnson DA
Am J Gastroenterol; 2008 Apr; 103(4):815-9. PubMed ID: 18397418
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
Dobrek Ł; Thor PJ
Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin and lubiprostone: the best options for treating irritable bowel syndrome?
Purslow C
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):263. PubMed ID: 22816171
[No Abstract] [Full Text] [Related]
16. [A new remedy for diarrheal irritable bowel syndrome].
Storr M
MMW Fortschr Med; 2016 Mar; 158(5):43. PubMed ID: 26979218
[No Abstract] [Full Text] [Related]
17. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
18. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
[TBL] [Abstract][Full Text] [Related]
19. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
Horwitz BJ
Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
[No Abstract] [Full Text] [Related]
20. Treatment approaches to irritable bowel syndrome.
Sood MR
Pediatr Ann; 2009 May; 38(5):272-6. PubMed ID: 19476300
[No Abstract] [Full Text] [Related]
[Next] [New Search]
